S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
New AI Stock Payouts (Ad)
Are Gene Therapy Stocks The Market's Next Big Winners?
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
New AI Stock Payouts (Ad)
Are Gene Therapy Stocks The Market's Next Big Winners?
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
New AI Stock Payouts (Ad)
Are Gene Therapy Stocks The Market's Next Big Winners?
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
S&P 500   4,337.44
DOW   34,006.88
QQQ   359.61
3 Blue Chip Safe Havens to Shield Your Portfolio
New AI Stock Payouts (Ad)
Are Gene Therapy Stocks The Market's Next Big Winners?
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
3 Stocks That Flourish In The Fall
Buy The World’s Largest IT Infrastructure Provider For Under $20
Experts: "NVIDIA Bubble" Could Affect Entire Market (Ad)
2 Must-Have Silicon Companies That Don't Make Microchips
Small Caps That Have Priced In A Hard Landing For Big Upside
NASDAQ:KEQU

Kewaunee Scientific (KEQU) Stock Forecast, Price & News

$17.45
0.00 (0.00%)
(As of 09/25/2023 ET)
Compare
Today's Range
$17.45
$17.45
50-Day Range
$14.66
$18.60
52-Week Range
$14.56
$19.15
Volume
97 shs
Average Volume
2,534 shs
Market Capitalization
$50.67 million
P/E Ratio
12.83
Dividend Yield
N/A
Price Target
N/A

Kewaunee Scientific MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
0.54% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$27,341 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.49 out of 5 stars


KEQU stock logo

About Kewaunee Scientific (NASDAQ:KEQU) Stock

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.

KEQU Price History

KEQU Stock News Headlines

BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Pre-market Movers: EOSE, ADTX, ICCT, NTNX, ESTC…
KEQU - Kewaunee Scientific Corporation
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Track Covid-19 in Kewaunee County, Wisconsin
Kewaunee High School
Fiscal Year 2023 First Quarter Results:
Kewaunee Scientific GAAP EPS of -$0.27, revenue of $50.12M
Kewaunee Scientific Corp - Stock Financials KEQU
Kewaunee Scientific Corp - Stock Quote KEQU
See More Headlines
Receive KEQU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kewaunee Scientific and its competitors with MarketBeat's FREE daily newsletter.

KEQU Company Calendar

Last Earnings
8/31/2023
Today
9/25/2023
Next Earnings (Estimated)
12/06/2023
Fiscal Year End
4/30/2024

Industry, Sector and Symbol

Industry
Laboratory apparatus & furniture
Sub-Industry
N/A
Current Symbol
NASDAQ:KEQU
Employees
982
Year Founded
1906

Profitability

Net Income
$740,000.00
Pretax Margin
3.76%

Debt

Sales & Book Value

Annual Sales
$219.21 million
Cash Flow
$1.27 per share
Book Value
$13.60 per share

Miscellaneous

Free Float
2,483,000
Market Cap
$50.67 million
Optionable
Not Optionable
Beta
0.37

Social Links

10 Best Stocks to Own in 2023 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Thomas D. Hull III (Age 47)
    Pres, CEO & Director
    Comp: $740.68k
  • Mr. Donald T. Gardner III (Age 44)
    VP of Fin., CFO, Treasurer & Sec.
    Comp: $476.84k
  • Mr. Douglas J. Batdorff (Age 50)
    VP of Manufacturing Operations
    Comp: $379.75k
  • Mr. Ryan S. Noble (Age 45)
    VP of Sales & Marketing - Americas
  • Ms. Elizabeth D. Phillips (Age 46)
    VP of HR
  • Mr. Bhoopathy Sathyamurthy (Age 54)
    MD of International Operations & VP of Kewaunee Scientific Corp. Singapore Pte. Ltd.













KEQU Stock - Frequently Asked Questions

How have KEQU shares performed in 2023?

Kewaunee Scientific's stock was trading at $15.95 at the beginning of 2023. Since then, KEQU shares have increased by 9.4% and is now trading at $17.45.
View the best growth stocks for 2023 here
.

Are investors shorting Kewaunee Scientific?

Kewaunee Scientific saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 11,500 shares, an increase of 21.1% from the August 15th total of 9,500 shares. Based on an average daily volume of 2,400 shares, the short-interest ratio is currently 4.8 days. Approximately 0.5% of the shares of the company are short sold.
View Kewaunee Scientific's Short Interest
.

When is Kewaunee Scientific's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, December 6th 2023.
View our KEQU earnings forecast
.

How were Kewaunee Scientific's earnings last quarter?

Kewaunee Scientific Co. (NASDAQ:KEQU) released its quarterly earnings data on Thursday, August, 31st. The technology company reported $0.86 earnings per share (EPS) for the quarter. The technology company had revenue of $49.84 million for the quarter. Kewaunee Scientific had a trailing twelve-month return on equity of 10.53% and a net margin of 1.81%.

Is Kewaunee Scientific a good dividend stock?

Kewaunee Scientific (NASDAQ:KEQU) pays an annual dividend of $0.76 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 55.88%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for KEQU.

What is William A. Shumaker's approval rating as Kewaunee Scientific's CEO?

5 employees have rated Kewaunee Scientific Chief Executive Officer William A. Shumaker on Glassdoor.com. William A. Shumaker has an approval rating of 100% among the company's employees. This puts William A. Shumaker in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Kewaunee Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kewaunee Scientific investors own include Carnival Co. & (CCL), Magnachip Semiconductor (MX), AT&T (T), Verizon Communications (VZ), AbbVie (ABBV), Alphabet (GOOG), KEMET (KEM), Micron Technology (MU), Energy Transfer (ET).

What is Kewaunee Scientific's stock symbol?

Kewaunee Scientific trades on the NASDAQ under the ticker symbol "KEQU."

Who are Kewaunee Scientific's major shareholders?

Kewaunee Scientific's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Northern Trust Corp (10.63%), Dimensional Fund Advisors LP (6.00%), Renaissance Technologies LLC (2.76%), BlackRock Inc. (0.45%) and Acadian Asset Management LLC (0.23%). Insiders that own company stock include David S Rhind, David S Rhind, Donald F Shaw, Donald T Gardner III, Elizabeth D Phillips, John Russell, Keith M Gehl and Thomas David Hull III.
View institutional ownership trends
.

How do I buy shares of Kewaunee Scientific?

Shares of KEQU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Kewaunee Scientific's stock price today?

One share of KEQU stock can currently be purchased for approximately $17.45.

How much money does Kewaunee Scientific make?

Kewaunee Scientific (NASDAQ:KEQU) has a market capitalization of $50.67 million and generates $219.21 million in revenue each year. The technology company earns $740,000.00 in net income (profit) each year or $1.36 on an earnings per share basis.

How many employees does Kewaunee Scientific have?

The company employs 982 workers across the globe.

How can I contact Kewaunee Scientific?

Kewaunee Scientific's mailing address is 2700 W FRONT ST, STATESVILLE NC, 28677. The official website for the company is www.kewaunee.com. The technology company can be reached via phone at (704) 873-7202, via email at mikeparker@kewaunee.com, or via fax at 704-873-5160.

This page (NASDAQ:KEQU) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -